What's Happening?
Crown Bioscience, a global contract research organization, has opened a new model development center in Kannapolis, North Carolina. This facility aims to enhance the company's ability to deliver advanced preclinical oncology models, including patient-derived xenografts and organoids. The expansion aligns with Crown Bioscience's strategy to provide localized access to global scientific expertise and top-quality preclinical services.
Why It's Important?
The new center strengthens Crown Bioscience's US presence, supporting the growing demand for innovative and scalable models in drug development. It will contribute to the local economy through job creation and training initiatives, attracting scientific expertise to the region. The facility's focus on 3D cell culture and organoid technologies positions Crown Bioscience as a leader in precision medicine and oncology research.
What's Next?
The Kannapolis site is expected to become fully operational in October, broadening its service capabilities. It will support Crown Bioscience's model platform portfolio and foster collaboration with other facilities. The expansion may lead to advancements in drug development, offering more advanced models and solutions to clients.
